Accelerating cancer research and innovation in comprehensive cancer infrastructures

Accelerating cancer research and innovation in comprehensive cancer infrastructures



Chairs: Maja Cemažar, Mef Nilbert, Johan Van Lint

Introduction

CCI4EU (Comprehensive Cancer Infrastructures for the European Union) is a European project aiming to help Member States and Associated Countries improve or develop their existing or future Comprehensive Cancer Infrastructures (CCIs), by helping develop their research & innovation-related capacities.

The CCI4EU project will run over 3 years, it will define and create a Maturity Model with quality indicators, to map the status of CCIs in all Member States and in five Associated Countries. Up to 9 sites have been selected for Deep Dive interventions, with 3 onsite visits to help them build their capacity in particular domains. Along with this, tailored online courses, resources and conferences are being developed to open up the capacity building to a wider audience, with the overall aim of contributing to the Horizon Europe Mission of ensuring that 90% of eligible cancer patients have access to Comprehensive Cancer Infrastructures by 2030.

This Conference is the second of three that will be held over the course of the project. It will give individuals and teams from developing CCIs direction in helping them build their capacity and develop their infrastructures. The topic of this second conference is: Accelerating cancer research and innovation in comprehensive cancer infrastructures

The gap between research findings and clinical implementation poses a significant challenge in healthcare. Bridging this gap is essential to ensure that the latest evidence is incorporated into patient care effectively. This conference is aimed at professionals involved in translational research, clinical trialists, directors of science and hospital leaders.

Learning Objectives:
  • Understand the importance of capacity building in research and innovation.
  • Learn how to develop/improve biobanking, registries and screening programmes.
  • Identify the ways to bring research findings into clinical settings.
  • Enhance collaboration between stakeholders and other research centres.
  • Explore real-world case studies and examples of successful/unsuccessful of ongoing research, innovation and patent cases

ATTENDANCE TO THE CONFERENCE IS BY APPLICATION ONLY

This conference is part of the CCI4EU project funded by the European Union.

Conference Structure

The conference will be a combination of lectures by international experts, discussions and breakout sessions.

During the breakout sessions some selected participants will be given the opportunity to present case studies of their own experience in research and clinical implementation (success stories, trials that didn’t work, trials that are ongoing with issues that need to be resolved).
The faculty & participants will discuss these cases studies in small groups.

Participant’s profile

As this is an EU funded project, the conference is open to anyone coming from EU Member States and the following associated countries: Albania, Georgia, Moldova, Ukraine and Norway.

Priority will be given to delegates from CCIs with a low maturity according to the Maturity Model Mapping. Priority will also be given to multidisciplinary teams from such CCIs, not isolated individuals. In particular we are looking for:

  • People/researchers involved in translational research
  • Clinical trialists
  • Directors of science/department leaders
  • People involved in IP and TT offices
  • Hospital leaders

Attendance to the conference is on application basis, 100 participants will be selected to attend.
All participants will have their flights and accommodation organized and paid for by the project.

Fluency in English is required.

Location

The conference will be held at Fondation Universitarie Brussels
It will begin at 08:30 on 9 April 2025 and end at 12:15 on 10 April 2025.

Accommodation and Travel

2 night’s accommodation (8 & 9 April 2024) at The Hotel Brussels will be organized for all selected participants.
Flights/Trains to and from Brussels will be organized by the conference travel agency.
Extra accommodation and accompanying guest will not be covered or organised by the project, nor will extra travel costs such as taxi, car park, etc.

Language

The course will be held in English and translation will not be provided.

Insurance

The organisers bear no responsibility for untoward events in relation to the participation in the event. Participants will be advised to take out their own personal and travel insurance coverage.

09/04/2025 08:00

Registration


09/04/2025 08:30

Welcome and introduction

Maja Cemazar (SI) Mef Nilbert (SE) Johan Van Lint (BE)

09/04/2025 08:40

National research collaborations


09/04/2025 08:40

The Belgian example

Johan Van Lint (BE)

09/04/2025 09:00

Discussion


09/04/2025 09:10

Screening


09/04/2025 09:10

EU regulation and the new approach to cancer screening

Urska Ivanus (SI)

09/04/2025 09:30

Lung cancer screening

Miroslav Samarzija (HR)

09/04/2025 09:40

Discussion


09/04/2025 10:00

Coffee break and networking


09/04/2025 10:30

Biobanking


09/04/2025 10:30

Best Practices from IARC

Zisis Kozlakidis (FR)

09/04/2025 10:50

European Research Infrastructures: Key contributors to advancing cancer research and innovation

Manuela Pausan (AT)

09/04/2025 11:10

Discussion


09/04/2025 11:30

Collaboration in research


09/04/2025 11:30

What does EORTC expect from a CCI to collaborate?

Gaetan de Schaetzen (BE)

09/04/2025 11:50

Leveraging real-world data in multinational collaborations to improve clinical practice and quality of care

Tarec Christoffer El-Galaly (DK)

09/04/2025 12:05

Discussion


09/04/2025 12:25

Cancer registries


09/04/2025 12:25

IARC role in creating synergies

Ariana Znaor (FR)

09/04/2025 12:45

Role of the cancer registries in clinical quality

Giske Ursin (NO)

09/04/2025 13:05

Discussion


09/04/2025 13:25

Lunch


09/04/2025 14:25

Breakout session 1 (4 groups + 2 Faculty members in each group, 4 cases per group)


09/04/2025 16:25

Coffee break


09/04/2025 16:55

Breakout session 2 (4 groups + 2 Faculty members in each group, 4 cases per group)


09/04/2025 18:55

End of Day 1


09/04/2025 19:00

Working cocktail dinner at the Fondation Universitaire

10/04/2025 08:30

Experience of extending capacity in (translational) research


10/04/2025 08:30

The Czech Republic experience

Aleksi Sedo (CZ)

10/04/2025 08:50

The Slovenian experience

Maja Cemazar (SI)

10/04/2025 09:10

Discussion


10/04/2025 09:30

Data


10/04/2025 09:30

Implications of the development of the European Health Data Space on cancer data.

Magdalena Rosinska (PL)

10/04/2025 09:50

Clinical data to be used for research purposes

Alberto Traverso (IT)

10/04/2025 10:00

Discussion


10/04/2025 10:20

Coffee break


10/04/2025 10:50

How to help early/mid-career researchers? How to build a career structure that will attract and retain a good researcher?


10/04/2025 10:50

The example of Bulgaria

Assia Konsoulova (BG)

10/04/2025 11:05

The eample of Italy

Alberto Traverso (IT)

10/04/2025 11:20

The example of Belgium

Deb Vansteenwegen (BE)

10/04/2025 11:35

Discussion


10/04/2025 12:00

Closing remarks

Maja Cemazar (SI) Johan Van Lint (BE)

10/04/2025 12:15

Lunch and departures

Alberto Traverso profile photo
Alberto Traverso

IRCCS San Raffaele Hospital, Department of Artificial Intelligence, Milano, IT

Aleksi Sedo profile photo
Aleksi Sedo

National Cancer Research Institute Prague, Director of the National Cancer Research Institute, Prague, CZ

Ariana Znaor profile photo
Ariana Znaor

IARC, International Agency for Research on Cancer, Scientist Cancer Surveillance, CS 90627 69366 LYON, FR

Assia Konsoulova profile photo
Assia Konsoulova

National Cancer Hospital, Medical Oncology Clinic, Sofia, BG

Deb Vansteenwegen profile photo
Deb Vansteenwegen

KU Leuven, Leuven, BE

Gaetan de Schaetzen profile photo
Gaetan de Schaetzen

EORTC, European Organisation for Research and Treatment of Cancer, Belgium, BE

Giske Ursin profile photo
Giske Ursin

Cancer Registry of Norway, Norwegian Institute of Public Health, Oslo, NO

Johan Van Lint profile photo
Johan Van Lint

Leuven Cancer Institute (LKI), Leuven, BE

Magdalena Rosinska profile photo
Magdalena Rosinska

Maria Sklodowska-curie National Cancer Institute, Digital Medicine Centre, Warsaw, PL

Maja Cemazar profile photo
Maja Cemazar

Institute of Oncology Ljubljana, Head of Research and Education, Ljubljana, SI

Manuela Pausan profile photo
Manuela Pausan

BBMRI-ERIC European research infrastructure for biobanking, BBMRI-ERIC, Graz, AT

Mef Nilbert profile photo
Mef Nilbert

Lund University, Dept. Oncology, Institute for Clinical Sciences, Lund, SE

Miroslav Samarzija profile photo
Miroslav Samarzija

Clinical Hospital Center Zagreb, Department of Pulmonary Diseases, Zagreb, HR

Tarec Christoffer El-Galaly profile photo
Tarec Christoffer El-Galaly

Aalborg Universitetshospital, Department of Clinical Medicine, Aalborg, DK

Urska Ivanus profile photo
Urska Ivanus

Institute Of Oncology Ljubljana, Epidemiology and Cancer Registries, Ljubljana, SI

Zisis Kozlakidis profile photo
Zisis Kozlakidis

International Agency for Research on Cancer, Head, Laboratory Services and Biobank Group, Lyon, FR

Attendance to the conference is on application basis, 100 participants will be selected to attend. Interested candidates should apply online providing the following:

  • CV & list of publications;
  • Motivation letter (if you are applying as a member of a team, please state this here);
  • Completed template for the Research and Innovation Case Studies (template here)

Priority will be given to delegates from CCIs with a low maturity according to the Maturity Model Mapping. Priority will also be given to multidisciplinary teams from such CCIs, not isolated individuals.

Research and Innovation Case Studies

Please complete the attached template giving an example of research and innovation you have worked on: it could be a study that worked and was a success, something that didn’t work or that is ongoing with issues that need to be resolved.

Some selected participants will have the opportunity to present their example in the format of a slide presentation (max. 10) to the participants and faculty members during the breakout sessions (as mentioned in the programme). Please don’t submit presentations at this stage in the application process.

Case studies from teams will also be accepted and the whole participating team should be mentioned in the template.

ATTENDANCE TO THE COURSE IS BY APPLICATION ONLY

Successful applicants are granted:

- free registration, accommodation and meals (as stated in the programme), flights to and from the location.

APPLICATION DEADLINE: 02.02.2025